Rankings
▼
Calendar
SCLX Q4 2024 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena
SCLX
Scilex Holding Company
$73M
Q4 2024 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$15M
+10.7% YoY
Gross Profit
$10M
68.5% margin
Operating Income
-$28M
-190.5% margin
Net Income
-$6M
-43.4% margin
EPS (Diluted)
$-1.23
QoQ Revenue Growth
+3.2%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
$2M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$93M
Total Liabilities
$286M
Stockholders' Equity
-$193M
Cash & Equivalents
$3M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15M
$13M
+10.7%
Gross Profit
$10M
$8M
+29.1%
Operating Income
-$28M
-$18M
-54.7%
Net Income
-$6M
-$21M
+69.8%
← FY 2024
All Quarters
Q1 2025 →